Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Item

http://www.wikidata.org/entity/Q34523702

Q34523702

about

Nicotine receptor partial agonists for smoking cessation Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Breathing SPACE-a practical approach to the breathless patient.Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG Tobacco smoking: Health impact, prevalence, correlates and interventions Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.Evaluating an Adaptive and Interactive mHealth Smoking Cessation and Medication Adherence Program: A Randomized Pilot Feasibility Study.Factors moderating the relative effectiveness of varenicline and nicotine replacement therapy in clients using smoking cessation services.An appraisal of practice guidelines for smoking cessation in people with severe mental illness.Qualitative analysis of social network influences on quitting smoking among individuals with serious mental illness.How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.Treatment with bupropion and varenicline for smoking cessation and the risk of acute cardiovascular events and injuries: a Swedish case-crossover study.A Retrospective Analysis of the Outcomes of Smoking Cessation Pharmacotherapy Among Persons With Mental Health and Substance Use Disorders.Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.Preferences for Smoking Cessation Support from Family and Friends Among Adults with Serious Mental Illness.Smoking, Mental Illness, and Public Health.Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care.Australian mental health care practitioners' practices and attitudes for encouraging smoking cessation and tobacco harm reduction in smokers with severe mental illness.Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline.Implementation of a tobacco-free workplace program at a local mental health authority.Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme.The Food and Drug Administration and varenicline: should risk communication be improved?Current status and future prospects for the development of substance abuse vaccines.Cue-induced nicotine-seeking behavior after withdrawal with or without extinction in rats.Smoking is the first cause of morbidity and death in psychiatric settings.Brief Web-Based Interventions for Young Adult Smokers With Severe Mental Illnesses: A Randomized, Controlled Pilot Study.Effectiveness of Pharmaceutical Smoking Cessation Aids in a Nationally Representative Cohort of American Smokers.Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.Effect of Patient Navigation and Financial Incentives on Smoking Cessation Among Primary Care Patients at an Urban Safety-Net Hospital: A Randomized Clinical Trial.Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial."I Smoke Like This to Suppress These Issues That Are Flaws of My Character": Challenges and Facilitators of Cessation Among Smokers With Bipolar Disorder.Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records.Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use.

P2860

Q24185773-DC0234C9-C11F-4B29-803A-1DCFB3110CD2 Q30238784-072E6B9C-685D-43BA-A5EC-9EDFBC6F9528 Q33697698-E506AA2D-4CD4-4233-AF24-A0BC21A88306 Q33784570-F975E79B-4D21-4E64-AE10-AD06161528DB Q33852243-785075E4-537A-4D32-A014-4AE699F037C6 Q33909736-801B8FF9-7E2C-466E-845D-DFEB7F9D16F7 Q36205741-69987412-853B-4BF7-A307-E95C55B3F296 Q37184722-C7B5D42B-F041-4EA2-8508-DFE55E2EE42C Q38626470-93D92EB2-71E7-431D-BDC1-177DE5069833 Q38634848-2879477F-AD75-4386-9858-5018969F9696 Q38694700-C8374DCA-3F04-4197-A2C2-2BB3FD7F20D0 Q38720906-7E0AF65A-1980-4BB5-BE44-D13722423E4B Q38729731-66B35733-4865-4876-A015-E983796A8331 Q38736026-01B7DEA8-C4DA-4778-BEB6-816D731AD8E6 Q38760849-86482DB0-5221-4518-AB7C-B2B38FEB2E3E Q38822654-093CA2D8-0EAA-4CF2-932D-2530C8A15C6D Q38834502-4F10F542-01A7-4CDC-8D8F-9DF449EF14BB Q39018795-ED3964C5-ADDD-48C6-9F8E-3FC0A9843128 Q39043292-E31FCBEC-41E2-43BC-AA26-56488A010111 Q39333786-04704EE1-26D7-4AC1-927D-34D10035AEDF Q40102553-7BBCFFE1-49D1-4C90-8C29-FB305960462E Q40138630-FB41392C-2713-453A-B840-722B9A20F258 Q40350164-215F86A4-7BCC-40A4-827D-98B91CFC4A78 Q41035791-622561EC-4E06-4149-A6E3-0024A3309D91 Q41122923-5A3709F1-06AB-458F-96BC-8EF3A12C2A8F Q41481498-C02E848D-D845-4BAC-A9E0-E96EE9D30B62 Q42316790-7B71433A-9870-47D9-9DF9-C19B87115A34 Q43076031-D7B9412B-911B-4B09-ACDF-BE0BFE274449 Q46092666-CF657693-8BC7-4C42-A14E-CDBD99A923F0 Q47159474-9B8C96B1-770A-41AE-87A3-70D2346D1EFF Q47236676-3DE5FDD8-A1C3-4565-A7ED-11F7F0B62F26 Q47243833-E616835A-D2FF-4C5F-8E3F-45541A48AAC5 Q47275723-DE2130E9-5016-4B9D-BEC2-25DF0728DABB Q47310677-DF59E2E8-4549-42D6-9C2C-6ECEB2312C27 Q47373861-2BFAFE8F-CF53-4254-907A-51B4ED6FD996 Q47385078-906F6D89-FCF7-4C8C-BBC3-5669108AA8C8 Q47557003-66E9F32C-4E1E-43F6-AAC3-92CA9EF9B7CA Q47591480-5C9DB876-2F33-47E4-91F6-DBC1FC3CB0CA Q47651619-B2E30B50-BB83-4F03-A513-391E0232871F Q47677476-7B1B5F25-488B-490B-908C-74716EBAC722

P2860

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Item

http://www.wikidata.org/entity/Q34523702

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu